SEEGENE ANYPLEX II HSV-1/2 ASSAY
Feb 2015
191d
Seegene has submitted 1 FDA 510(k) premarket notifications since 2015, of which 1 received clearance as substantially equivalent to a predicate device.
The company's most frequent device categories include Herpes Simplex Virus Nucleic Acid Amplification Assay . Use the specialty filter in the sidebar to narrow results.